Physical- and Chemical-Dually ROS-Responsive Nano-in-Gel Platforms with Sequential Release of OX40 Agonist and PD-1 Inhibitor for Augmented Combination Immunotherapy
Abstract
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Peptidase Inhibition and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China
Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford OX1 2JD, U.K.
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Harvard University, Charlestown, Massachusetts 02138, United States
Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University/Army Medical University, Chongqing 400038, P.R. China
Funding
Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Natural Science Foundation of Chongqing, China · Doctoral Through Train Scientific Research Project of Chongqing · Sichuan Science and Technology Program · Innovative Research Group at Higher Educational Institutions in Chongqing